It has been a day of mixed fortunes for healthcare names on both sides of the Atlantic, says Chris Beauchamp, Chief Market Analyst at online trading platform IG.
FTSE 100 rebounds, helped by AstraZeneca
AstraZeneca’s numbers have put the fight back in the FTSE 100 as investors around the world gear up for a busy 48 hours of earnings and central bank news. Index heavyweight AstraZeneca provided plenty of good news for UK investors on an otherwise poor day for healthcare stocks; both Novo Nordisk and United Health have come under pressure after bad news, though the former’s surge in earnings seems to suggest the market may now be too cautious on the outlook.
Oil rises for a second day
Easing fears around a global trade war have helped to push oil prices higher for a second consecutive session. Trump’s promises of sanctions on Russia if no Ukraine deal is forthcoming seem a bit far-fetched given his previous views, but the news has certainly helped beaten-down oil prices to make some reasonable short-term headway.
作者：Chris Beauchamp，文章来源FXStreet，版权归原作者所有，如有侵权请联系本人删除。
风险提示：以上内容仅代表作者或嘉宾的观点，不代表 FOLLOWME 的任何观点及立场，且不代表 FOLLOWME 同意其说法或描述，也不构成任何投资建议。对于访问者根据 FOLLOWME 社区提供的信息所做出的一切行为，除非另有明确的书面承诺文件，否则本社区不承担任何形式的责任。
FOLLOWME 交易社区网址: www.followme.ceo
加载失败()